Literature DB >> 7137828

Cholecystokinin metabolism in normal man and patients with duodenal ulcer.

N I Ramus.   

Abstract

Using two cholecystokinin (CCK) radioimmunoassays CCK has been shown to be heterogeneous (CCK-33 and CCK-8) after both exogenous infusion and endogenous release. CCK-39 (CCK variant) was not separated after endogenous CCK stimulation but was identified after the exogenous infusion of 16% pure CCK. The disappearance half-time of 16% pure CCK has been shown to be 2.4 min and one major organ of catabolism identified--the kidney. Degradation of CCK by whole blood occurred after standing for 2 h, but if separation was carried out immediately serum could be left for 6 h before any further degradation took place. Serum appeared to retain its CCK activity more reliably than plasma. Abnormalities in CCK release in duodenal ulcer disease, which are further altered by highly selective vagotomy (HSV), have been demonstrated. Pancreatic exocrine function was not significantly altered by HSV. CCK release and disappearance are more rapid in patients with duodenal ulceration. This observation may be aetiologically important since unopposed postprandial hypergastrinaemia in the absence of effective inhibition by CCK might lead to increased gastric acid production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137828      PMCID: PMC2494071     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  12 in total

1.  Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine.

Authors:  A A Harper; H S Raper
Journal:  J Physiol       Date:  1943-06-30       Impact factor: 5.182

2.  Simple method for estimating trypsin.

Authors:  H S Wiggins
Journal:  Gut       Date:  1967-08       Impact factor: 23.059

3.  Gastrin, cholecystokinin, and secretin act on one receptor.

Authors:  M I Grossman
Journal:  Lancet       Date:  1970-05-23       Impact factor: 79.321

4.  Effect of secretin on circulating gastrin.

Authors:  J C Thompson; D D Reeder; H H Bunchman; H D Becker; E N Brandt
Journal:  Ann Surg       Date:  1972-09       Impact factor: 12.969

5.  The renal uptake and excretion of insulin in the dog.

Authors:  R Rabkin; J A Colwell
Journal:  J Lab Clin Med       Date:  1969-06

6.  The assay of endogenous cholecystokinin and factors influencing its release in the dog and cat.

Authors:  H Berry; R J Flower
Journal:  Gastroenterology       Date:  1971-03       Impact factor: 22.682

7.  Renal uptake and excretion of gastrin in the dog.

Authors:  B G Clendinnen; W D Davidson; D D Reeder; B M Jackson; J C Thompson
Journal:  Surg Gynecol Obstet       Date:  1971-06

8.  Hormonal content and effect on gallbladder of commercial preparations of cholecystokinin-pancreozymin.

Authors:  R F Harvey; J M Oliver
Journal:  Horm Metab Res       Date:  1981-08       Impact factor: 2.936

9.  Gastric, pancreatic, and biliary secretion and the rate of gastric emptying after parietal cell vagotomy.

Authors:  M E Lavigne; Z D Wiley; P Martin; L W Way; J H Meyer; M H Sleisenger; I L MacGregor
Journal:  Am J Surg       Date:  1979-11       Impact factor: 2.565

10.  Pure human big gastrin. Immunochemical properties, disappearance half time, and acid-stimulating action in dogs.

Authors:  J H Walsh; H T Debas; M I Grossman
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.